| mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |